![Biology / Growth hormones / Growth factors / Endocrinology / Recombinant proteins / Insulin-like growth factor 1 / Mecasermin / Insulin-like growth factor / Laron syndrome / Endocrine system / Peptide hormones / Medicine Biology / Growth hormones / Growth factors / Endocrinology / Recombinant proteins / Insulin-like growth factor 1 / Mecasermin / Insulin-like growth factor / Laron syndrome / Endocrine system / Peptide hormones / Medicine](https://www.pdfsearch.io/img/717de1bc9e51f7009687b4258bedc9db.jpg)
| Document Date: 2013-08-13 12:09:53 Open Document File Size: 318,79 KBShare Result on Facebook
Company All Wales Medicines Strategy Group / / Country United States / United Kingdom / Wales / / Currency GBP / / Event FDA Phase / / Facility National Institute of Health / / IndustryTerm orphan medicinal product / Treatment of Growth Failure / / MedicalCondition malnutrition / insulin resistance / This disorder / disease / hypothyroidism / learning disability / chronic treatment / genetic disorder / Introduction Growth hormone insensitivity syndrome / muscle weakness / bone disease / severe primary insulin-like growth factor1 deficiency / Laron syndrome / obesity / disorder / osteoporosis / growth disorders / autosomal recessive disorder / deficiency / GH deficiency / syndrome / disorders / / MedicalTreatment hormone treatment / / Organization NHS Commissioning Board / National Institute of Health / European Union / NHS / The Bedfordshire and Luton Joint Prescribing Committee / / Product Mecasermin / Lupron / Increlex / Increlex® / / Technology one protocol / antibodies / GPS / recombinant DNA / /
SocialTag |